Leucovorin: all 351 studies that test it
Page 3 of 4. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerCompletedNCT03067792Phase 3
- Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-FluorouracilStatus unknownNCT02987699Phase 2
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsCompletedNCT02980510Phase 2
- PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon CancerStatus unknownNCT02959541Not applicable
- FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer PatientsStatus unknownNCT02935764Phase 3
- Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus CetuximabCompletedNCT02934529Phase 3
- A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid TumorsCompletedNCT02884128Phase 1
- POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGCCompletedNCT02845908Phase 2
- Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum DisorderActive, not recruitingNCT02839915Phase 2
- Folinic Acid: Supplementation and TherapyCompletedNCT02810275Phase 3
- Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal CancerWithdrawnNCT02785068Phase 1/2
- Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
- Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerStatus unknownNCT02688023Phase 2
- Folinic Acid in Children With Autism Spectrum DisordersStatus unknownNCT02551380Phase 2
- A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaCompletedNCT02539537Phase 3
- Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the EsophagusActive, not recruitingNCT02509286Phase 3
- Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
- The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation OutcomeStatus unknownNCT02506231Phase 2/3
- Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy PatientsCompletedNCT02456844Phase 1
- RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCCStatus unknownNCT02426450Phase 2
- Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver MetastasisWithdrawnNCT02345746Phase 2
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic MarkersWithdrawnNCT02296671Phase 2
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT02235324Phase 2
- Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological MalignanciesCompletedNCT02106650Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable PatientsStatus unknownNCT02099188Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable PatientsStatus unknownNCT02099175Phase 2
- Study of S-1 Plus LV for Advanced Gastric CancerCompletedNCT02090153Phase 2
- Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerWithdrawnNCT02046538Phase 2
- Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementActive, not recruitingNCT02008656Phase 2
- Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric CancerStatus unknownNCT01980407Phase 2
- A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesCompletedNCT01930552Phase 1
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaActive, not recruitingNCT01920737Phase 2
- Folinic Acid and Vascular Reactivity in HIVCompletedNCT01768182Not applicable
- A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX TherapyStatus unknownNCT01758666Not applicable
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
- Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal CancerTerminatedNCT01715363Phase 2
- Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
- Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
- Second Look Laparoscopy in Colorectal CancerStatus unknownNCT01628211Phase 2
- Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal CancerTerminatedNCT01613469Phase 2
- A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas CancerStatus unknownNCT01586611Phase 3
- Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasCompletedNCT01572324Phase 2
- Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownNCT01529164Phase 2
- Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric AdenocarcinomasCompletedNCT01504256Phase 2
- Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01494363Phase 2
- LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerCompletedNCT01485744Phase 1
- Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachCompletedNCT01472029Phase 2
- The Study of Metastatic Pancreatic AdenocarcinomaCompletedNCT01415713Phase 1/2
- Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable TumoursCompletedNCT01397019Phase 2
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric CarcinomaCompletedNCT01364376Not applicable
- Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionCompletedNCT01360086Phase 2
- Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon CancerStatus unknownNCT01308086Phase 3
- Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal AdenocarcinomaWithdrawnNCT01302613Phase 1/2
- Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerCompletedNCT01274624Phase 1
- Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean PatientsStatus unknownNCT01271582Phase 4
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal CancerCompletedNCT01269216Phase 2
- Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by SurgeryCompletedNCT01263171Phase 2
- Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based ChemotherapyTerminatedNCT01238965Phase 1
- Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast CancerStatus unknownNCT01231802Phase 2
- 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric CancerCompletedNCT01216644Phase 2/3
- Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal CancerCompletedNCT01205711Phase 2
- S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerStatus unknownNCT01193452Phase 2
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric CancerStatus unknownNCT01160419Phase 2
- Salvage mFOLFOX in BTC After Failure of GemcitabineCompletedNCT01127555Phase 2
- Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in ChinaCompletedNCT01110941Phase 1/2
- Study of S-1 as Second Line Treatment on Advanced Pancreatic CancersStatus unknownNCT01074996Phase 2
- A Study of Locally Advanced Pancreatic CancerStatus unknownNCT01063192Phase 2
- Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon CancerCompletedNCT01060501Phase 3
- Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal CarcinomaStatus unknownNCT01034683Phase 3
- Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal AdenocarcinomaStatus unknownNCT00964080Phase 1/2
- Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- CetuximabCompletedNCT00941499Phase 1
- Gemcitabine (GFF) in Patients With Pancreatic CancerCompletedNCT00919282Phase 2
- Does B Vitamin Supplementation Decrease Homocysteine Concentrations in NewbornsCompletedNCT00877227Phase 1
- Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical CancerTerminatedNCT00782041Phase 2
- Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT00764907Phase 3
- Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal CancerCompletedNCT00759226Phase 2
- Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric CancerCompletedNCT00632268Phase 2
- Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00559455Phase 2
- Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerStatus unknownNCT00524706Phase 1/2
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and AvastinCompletedNCT00507585Phase 1
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerCompletedNCT00501410Phase 1
- Phase I FOLFOX CombinationCompletedNCT00499850Phase 1
- H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisWithdrawnNCT00488605Phase 3
- A Study of Picoplatin in Colorectal CancerStatus unknownNCT00478946Phase 1/2
- Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCompletedNCT00471965Phase 3
- Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRCCompletedNCT00469443Phase 3
- Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric PatientsCompletedNCT00447967Phase 2
- Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00423696Phase 2
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryCompletedNCT00416767Phase 2
- Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the LiverStatus unknownNCT00408551Phase 2
- A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal CancerWithdrawnNCT00388700Phase 2
- ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal CancerTerminatedNCT00385021Phase 2
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric CancerStatus unknownNCT00384878Phase 2
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down SyndromeCompletedNCT00294593Phase 2/3